166 related articles for article (PubMed ID: 27881870)
1. Antibody-antigen kinetics constrain intracellular humoral immunity.
Bottermann M; Lode HE; Watkinson RE; Foss S; Sandlie I; Andersen JT; James LC
Sci Rep; 2016 Nov; 6():37457. PubMed ID: 27881870
[TBL] [Abstract][Full Text] [Related]
2. TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity.
Foss S; Watkinson RE; Grevys A; McAdam MB; Bern M; Høydahl LS; Dalhus B; Michaelsen TE; Sandlie I; James LC; Andersen JT
J Immunol; 2016 Apr; 196(8):3452-3459. PubMed ID: 26962230
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of CD27 in complex with a neutralizing noncompeting antibody.
Teplyakov A; Obmolova G; Malia TJ; Gilliland GL
Acta Crystallogr F Struct Biol Commun; 2017 May; 73(Pt 5):294-299. PubMed ID: 28471362
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA.
Maritan M; Cozzi R; Lo Surdo P; Veggi D; Bottomley MJ; Malito E
Acta Crystallogr F Struct Biol Commun; 2017 Jun; 73(Pt 6):305-314. PubMed ID: 28580917
[TBL] [Abstract][Full Text] [Related]
5. TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity.
Foss S; Watkinson R; Sandlie I; James LC; Andersen JT
Immunol Rev; 2015 Nov; 268(1):328-39. PubMed ID: 26497531
[TBL] [Abstract][Full Text] [Related]
6. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.
Bates JT; Keefer CJ; Utley TJ; Correia BE; Schief WR; Crowe JE
J Immunol; 2013 Apr; 190(7):3732-9. PubMed ID: 23455501
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
[TBL] [Abstract][Full Text] [Related]
8. The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human α
Borst AJ; James ZM; Zagotta WN; Ginsberg M; Rey FA; DiMaio F; Backovic M; Veesler D
Structure; 2017 Nov; 25(11):1732-1739.e5. PubMed ID: 29033288
[TBL] [Abstract][Full Text] [Related]
9. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21).
Mallery DL; McEwan WA; Bidgood SR; Towers GJ; Johnson CM; James LC
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19985-90. PubMed ID: 21045130
[TBL] [Abstract][Full Text] [Related]
10. Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains.
Turner HL; Pallesen J; Lang S; Bangaru S; Urata S; Li S; Cottrell CA; Bowman CA; Crowe JE; Wilson IA; Ward AB
PLoS Biol; 2019 Feb; 17(2):e3000139. PubMed ID: 30716060
[TBL] [Abstract][Full Text] [Related]
11. Ehrlichia chaffeensis Outer Membrane Protein 1-Specific Human Antibody-Mediated Immunity Is Defined by Intracellular TRIM21-Dependent Innate Immune Activation and Extracellular Neutralization.
Velayutham TS; Kumar S; Zhang X; Kose N; Walker DH; Winslow G; Crowe JE; McBride JW
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548319
[TBL] [Abstract][Full Text] [Related]
12. Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells.
Bidgood SR; Tam JC; McEwan WA; Mallery DL; James LC
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13463-8. PubMed ID: 25169018
[TBL] [Abstract][Full Text] [Related]
13. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.
Doud MB; Lee JM; Bloom JD
Nat Commun; 2018 Apr; 9(1):1386. PubMed ID: 29643370
[TBL] [Abstract][Full Text] [Related]
14. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21.
McEwan WA; Tam JC; Watkinson RE; Bidgood SR; Mallery DL; James LC
Nat Immunol; 2013 Apr; 14(4):327-36. PubMed ID: 23455675
[TBL] [Abstract][Full Text] [Related]
15. Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism.
Fan W; Zhang D; Qian P; Qian S; Wu M; Chen H; Li X
Antiviral Res; 2016 Mar; 127():32-40. PubMed ID: 26777733
[TBL] [Abstract][Full Text] [Related]
16. [Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates].
Mokrushina YA; Pipiya SO; Stepanova AV; Shamborant OG; Knorre VD; Smirnov IV; Gabibov AG; Vorobiev II
Mol Biol (Mosk); 2017; 51(6):958-968. PubMed ID: 29271960
[TBL] [Abstract][Full Text] [Related]
17. Evolving A RIG-I Antagonist: A Modified DNA Aptamer Mimics Viral RNA.
Ren X; Gelinas AD; Linehan M; Iwasaki A; Wang W; Janjic N; Pyle AM
J Mol Biol; 2021 Oct; 433(21):167227. PubMed ID: 34487794
[TBL] [Abstract][Full Text] [Related]
18. TRIM21-From Intracellular Immunity to Therapy.
Foss S; Bottermann M; Jonsson A; Sandlie I; James LC; Andersen JT
Front Immunol; 2019; 10():2049. PubMed ID: 31555278
[TBL] [Abstract][Full Text] [Related]
19. Rare missense variants in the human cytosolic antibody receptor preserve antiviral function.
Zeng J; Slodkowicz G; James LC
Elife; 2019 Oct; 8():. PubMed ID: 31613747
[TBL] [Abstract][Full Text] [Related]
20. Regulation of virus neutralization and the persistent fraction by TRIM21.
McEwan WA; Hauler F; Williams CR; Bidgood SR; Mallery DL; Crowther RA; James LC
J Virol; 2012 Aug; 86(16):8482-91. PubMed ID: 22647693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
